GlassScriptPhysician profile
Ashley Olszewski
NPI 1396462859
$653.70
in general payments reported to CMS, 2019-2025
16 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.58 · 2023: $253 · 2024: $183 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $230.87 | 2023-2025 | |
| Astellas Pharma US INC | $84.17 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $72.37 | 2023-2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $35.83 | 2023 | |
| Coopersurgical, INC. | $35.49 | 2023-2024 | Summit Doppler, Paragard T 380a |
| Millicent US INC | $28.16 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Radius Health, INC. | $24.70 | 2023 | Tymlos |
| Hologic Sales and Service, LLC | $18.42 | 2023 | Thinprep 2000 Processor, Aptima |
| Vertex Pharmaceuticals Incorporated | $17.21 | 2025 | |
| Abbvie INC. | $16.87 | 2024 | |
| Exeltis, USA INC. | $16.60 | 2024 | Slynd |
| Medtronic, INC. | $16.58 | 2022 | |
| Ethicon US, LLC | $14.50 | 2023 | Vistaseal, Dermabond, Stratafix |
| Merck Sharp & Dohme LLC | $14.28 | 2023 | Gardasil 9 |
| Organon LLC | $13.98 | 2025 | Nexplanon |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.67 | 2025 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Olszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.